Consultation is now open for items listed on the November 2022 PBAC agenda.
The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration.
The PBAC considers these public...More
Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 11-12 August 2022.
PASC values consultation input from individuals and organisations with an interest in an...More
The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment (HTA) and other matters (the Agreement) with Medicines Australia acting on behalf of the innovator medicines industry. As agreed under Clause 5.2 of the Agreement, advice...More
The Commonwealth has entered into a new Strategic Agreement in relation to reimbursement, health technology assessment (HTA) and other matters (the Agreement) with Medicines Australia acting on behalf of the innovator medicines industry. As agreed under Clause 5.2 of the Agreement, the...More
Consultation is now open for items listed on the July 2022 PBAC agenda.
The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration.
The PBAC considers these public...More
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 28-29 July 2022.
MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including...More
PBAC Intracycle meetings are held between the main PBAC meetings. Submission items considered by the PBAC at these meetings typically relate to matters arising from previous submissions but can also relate to new medicines.
The PBAC welcomes input from patients, carers, health...More
Consultation is now open for applications that are anticipated to be considered by the PICO Advisory Sub-Committee (PASC) of the Medical Services Advisory Committee (MSAC) on 13-14 April 2022.
PASC values consultation input from individuals and organisations with an interest in an...More
Consultation is now open for items listed on the March 2022 PBAC agenda.
The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines submitted for PBAC consideration.
The PBAC considers these public...More
Consultation is now open for applications that are anticipated to be considered by the Medical Services Advisory Committee (MSAC) on 31 March - 1 April 2022.
MSAC values consultation input from individuals and organisations with an interest in an application that it is considering, including...More